Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Adult Providing Access to the Visual Environment (PAVE) - Glaucoma Pilot (PAVE)

This study has been completed.
Information provided by (Responsible Party):
Karen Joos, Vanderbilt University Identifier:
First received: June 15, 2006
Last updated: August 19, 2015
Last verified: August 2015
We wish to evaluate a potential training program for patients with glaucoma, to become more efficient users of prescribed low vision devices for distance and near vision tasks. We hypothesize that the devices will improve efficiency. Prescribed devices will include a stand magnifier, a handheld magnifier, spectacle magnifiers for near vision, and a handheld monocular (telescope) and a bioptic telescope (spectacle-mounted telescope) for distance vision. The success of being able to use optical devices is dependent upon training. Optical devices are currently accepted and used for patients with visual conditions that decrease their central vision. The bioptic telescope is a pair of glasses with a small telescope mounted within the carrier lens. The glasses look and feel like a normal pair of glasses, but have a black device (telescope) protruding from the top of one lens for better identifying distance objects. The spectacle magnifier is mounted in a pair of glasses also for near vision

Condition Intervention
Behavioral: Training in the Use of Low Vision Devices

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Adult Providing Access to the Visual Environment (PAVE) - Glaucoma Pilot

Resource links provided by NLM:

Further study details as provided by Karen Joos, Vanderbilt University:

Primary Outcome Measures:
  • mobility [ Time Frame: At time of enrollment ]

Enrollment: 2
Study Start Date: October 2003
Study Completion Date: December 2011
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: No training
Subjects will be fitted with low vision devices; no extra training will be provided.
Experimental: Training in the Use of Low Vision Devices
Subjects will be fitted with low vision devices and will receive 6 training sessions with prescribed devices for up to 1 hour each time
Behavioral: Training in the Use of Low Vision Devices

Detailed Description:
You will be asked a series of oral questions regarding your health status and vision level of functioning (Expectations of Visual Functioning Form, NEI-VFQ, Linear Rating Scale, and Geriatric Depression Scale) in the Vanderbilt Eye Clinic. You will undergo a mobility pre-test to assess your ability to find objects in the distance as well as read . You will undergo a low vision examination in the eye clinic. You will receive the optical devices and then receive brief instructions on the use of the devices . You will then undergo a pre-training evaluation. You will receive approximately 6 training sessions with your prescribed devices for up to 1 hour each time. You will return to the Vanderbilt Eye Clinic for the post-training distance and near vision assessments with the devices . You will be asked the series of oral questions again regarding your health status and vision level of functioning .

Ages Eligible for Study:   21 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Glaucoma patients with vision less than 20/40

Exclusion criteria:

- Subjects must not have any significant physical mobility limitations and be willing to participate in the testing and training sessions.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00338208

United States, Tennessee
Vanderbilt University
Nashville, Tennessee, United States, 37232
Sponsors and Collaborators
Vanderbilt University
Principal Investigator: Karen Joos, MD, PhD Vanderbilt University
  More Information

Responsible Party: Karen Joos, Associate Professor of Ophthalmology, Vanderbilt University Identifier: NCT00338208     History of Changes
Other Study ID Numbers: Vanderbilt IRB #030642
Study First Received: June 15, 2006
Last Updated: August 19, 2015

Keywords provided by Karen Joos, Vanderbilt University:
low vision

Additional relevant MeSH terms:
Ocular Hypertension
Eye Diseases processed this record on May 25, 2017